GB9721693D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9721693D0
GB9721693D0 GBGB9721693.1A GB9721693A GB9721693D0 GB 9721693 D0 GB9721693 D0 GB 9721693D0 GB 9721693 A GB9721693 A GB 9721693A GB 9721693 D0 GB9721693 D0 GB 9721693D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9721693.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9721693.1A priority Critical patent/GB9721693D0/en
Publication of GB9721693D0 publication Critical patent/GB9721693D0/en
Priority to AU95470/98A priority patent/AU9547098A/en
Priority to YU28800A priority patent/YU28800A/sh
Priority to APAP/P/2000/001787A priority patent/AP2000001787A0/en
Priority to SK531-2000A priority patent/SK5312000A3/sk
Priority to NZ503862A priority patent/NZ503862A/xx
Priority to IL13551398A priority patent/IL135513A0/xx
Priority to BR9815219-0A priority patent/BR9815219A/pt
Priority to PCT/GB1998/003064 priority patent/WO1999018943A1/en
Priority to TR2000/00958T priority patent/TR200000958T2/xx
Priority to JP2000515578A priority patent/JP2001519382A/ja
Priority to IDW20000669A priority patent/ID24521A/id
Priority to CA002306086A priority patent/CA2306086A1/en
Priority to CN98812083A priority patent/CN1281359A/zh
Priority to EP98949086A priority patent/EP1023056A1/en
Priority to KR1020007003934A priority patent/KR20010024481A/ko
Priority to EA200000419A priority patent/EA002659B1/ru
Priority to CZ20001297A priority patent/CZ20001297A3/cs
Priority to OA1200000108A priority patent/OA11683A/en
Priority to PL98339813A priority patent/PL339813A1/xx
Priority to HU0003922A priority patent/HUP0003922A3/hu
Priority to NO20001898A priority patent/NO20001898L/no
Priority to HR20000255A priority patent/HRP20000255A2/hr
Priority to BG104404A priority patent/BG104404A/bg
Priority to US09/884,756 priority patent/US20010031776A1/en
Priority to US10/083,911 priority patent/US20020082284A1/en
Priority to NZ522730A priority patent/NZ522730A/xx
Priority to US10/313,201 priority patent/US20030069283A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9721693.1A 1997-10-13 1997-10-13 Novel treatment Ceased GB9721693D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
HU0003922A HUP0003922A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
CA002306086A CA2306086A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
EP98949086A EP1023056A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
APAP/P/2000/001787A AP2000001787A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia.
SK531-2000A SK5312000A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
NZ503862A NZ503862A (en) 1997-10-13 1998-10-12 Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia
IL13551398A IL135513A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
BR9815219-0A BR9815219A (pt) 1997-10-13 1998-10-12 Uso de tiazolidinedionas para o tratamento da hiperglicemia
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
TR2000/00958T TR200000958T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı.
JP2000515578A JP2001519382A (ja) 1997-10-13 1998-10-12 高血糖症治療のためのチアゾリジンジオンの使用
IDW20000669A ID24521A (id) 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia
AU95470/98A AU9547098A (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
CN98812083A CN1281359A (zh) 1997-10-13 1998-10-12 应用噻唑烷二酮类药物治疗高血糖症
YU28800A YU28800A (sh) 1997-10-13 1998-10-12 Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
KR1020007003934A KR20010024481A (ko) 1997-10-13 1998-10-12 고혈당증 치료용 티아졸리딘디온의 용도
EA200000419A EA002659B1 (ru) 1997-10-13 1998-10-12 Применение 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона для лечения гипергликемии
CZ20001297A CZ20001297A3 (cs) 1997-10-13 1998-10-12 Léčivo pro léčení hyperglykémie a farmaceutický prostředek s obsahem sensitizéru inzulinu
OA1200000108A OA11683A (en) 1997-10-13 1998-10-12 Use of thiahzolidinediones for the treatment of hyperglycaemia.
PL98339813A PL339813A1 (en) 1997-10-13 1998-10-12 Application of thiazolydine diones in treating hyperglycaemia
NO20001898A NO20001898L (no) 1997-10-13 2000-04-12 Anvendelse av tiazolidindioner for behandling av hyperglycaemi
HR20000255A HRP20000255A2 (en) 1997-10-13 2000-05-02 Use of thiazolidinediones for the treatment of hyperglycaemia
BG104404A BG104404A (bg) 1997-10-13 2000-05-05 Използване на тиазолидиндиони за лечение на хипергликемия
US09/884,756 US20010031776A1 (en) 1997-10-13 2001-06-19 Use of thiazolidinediones for the treatment of hyperglycaemia
US10/083,911 US20020082284A1 (en) 1997-10-13 2002-02-27 Use of thiazolidinediones for the treatment of hyperglycaemia
NZ522730A NZ522730A (en) 1997-10-13 2002-11-22 Use of thiazolidinediones for the treatment of hyperglycaemia
US10/313,201 US20030069283A1 (en) 1997-10-13 2002-12-06 Use of thiazolidinediones for the treatment of hyperglycaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
GB9721693D0 true GB9721693D0 (en) 1997-12-10

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9721693.1A Ceased GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Country Status (24)

Country Link
EP (1) EP1023056A1 (xx)
JP (1) JP2001519382A (xx)
KR (1) KR20010024481A (xx)
CN (1) CN1281359A (xx)
AP (1) AP2000001787A0 (xx)
AU (1) AU9547098A (xx)
BG (1) BG104404A (xx)
BR (1) BR9815219A (xx)
CA (1) CA2306086A1 (xx)
CZ (1) CZ20001297A3 (xx)
EA (1) EA002659B1 (xx)
GB (1) GB9721693D0 (xx)
HR (1) HRP20000255A2 (xx)
HU (1) HUP0003922A3 (xx)
ID (1) ID24521A (xx)
IL (1) IL135513A0 (xx)
NO (1) NO20001898L (xx)
NZ (1) NZ503862A (xx)
OA (1) OA11683A (xx)
PL (1) PL339813A1 (xx)
SK (1) SK5312000A3 (xx)
TR (1) TR200000958T2 (xx)
WO (1) WO1999018943A1 (xx)
YU (1) YU28800A (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
HUP0003922A3 (en) 2001-12-28
AU9547098A (en) 1999-05-03
SK5312000A3 (en) 2000-09-12
CA2306086A1 (en) 1999-04-22
NO20001898D0 (no) 2000-04-12
BG104404A (bg) 2000-12-29
EA200000419A1 (ru) 2000-10-30
OA11683A (en) 2005-01-12
EA002659B1 (ru) 2002-08-29
CN1281359A (zh) 2001-01-24
CZ20001297A3 (cs) 2001-08-15
AP2000001787A0 (en) 2000-06-30
KR20010024481A (ko) 2001-03-26
NZ503862A (en) 2003-01-31
NO20001898L (no) 2000-06-09
EP1023056A1 (en) 2000-08-02
JP2001519382A (ja) 2001-10-23
ID24521A (id) 2000-07-20
YU28800A (sh) 2003-02-28
PL339813A1 (en) 2001-01-02
HRP20000255A2 (en) 2001-02-28
TR200000958T2 (tr) 2000-08-21
WO1999018943A1 (en) 1999-04-22
BR9815219A (pt) 2001-01-02
HUP0003922A2 (hu) 2001-10-28
IL135513A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
GB9700899D0 (en) Novel treatment
GB9700939D0 (en) Therapy
ZA978359B (en) Novel treatment
GB9410512D0 (en) Novel treatment
GB9615767D0 (en) Novel treatment
GB9411635D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
TW366805U (en) Massager
GB9625795D0 (en) Novel treatment
GB9721692D0 (en) Novel treatment
GB2331514B (en) Effluent treatment
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9612752D0 (en) Novel treatment
GB9721693D0 (en) Novel treatment
GB9716742D0 (en) Treatment
GB9828550D0 (en) Treatment
GB9616413D0 (en) Novel treatment
GB9604046D0 (en) Novel treatment
GB9616414D0 (en) Novel treatment
GB9616412D0 (en) Novel treatment
GB9614739D0 (en) Novel treatment
GB9610986D0 (en) Novel treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)